One of the fundamental pillars of our strategy is innovation. We devoted about EUR 45 million to research and development in the 2020/2021 financial year.
Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.
Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October. In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products. Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Egis is present in 61 countries with its products.
Egis ’products are available in 61 countries. Our portfolio consists of 634 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.
Here you can find out more about our Rx products. Click on the link and learn about our prescription portfolio.
This content is for healthcare professionals only
Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Cookies necessary for basic functioning
These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.
Functional cookies
In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.
Cookies for statistical purposes
They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.